162 related articles for article (PubMed ID: 19118579)
1. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.
Garcia JM; Gao A; He PL; Choi J; Tang W; Bruzzone R; Schwartz O; Naya H; Nan FJ; Li J; Altmeyer R; Zuo JP
Antiviral Res; 2009 Mar; 81(3):239-47. PubMed ID: 19118579
[TBL] [Abstract][Full Text] [Related]
2. Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors.
Westby M; Nakayama GR; Butler SL; Blair WS
Antiviral Res; 2005 Sep; 67(3):121-40. PubMed ID: 16112209
[TBL] [Abstract][Full Text] [Related]
3. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
[TBL] [Abstract][Full Text] [Related]
4. DABOs as candidates to prevent mucosal HIV transmission.
Pani A; Musiu C; Loi AG; Mai A; Loddo R; La Colla P; Marongiu ME
Antivir Chem Chemother; 2001; 12 Suppl 1():51-9. PubMed ID: 11594689
[TBL] [Abstract][Full Text] [Related]
5. A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors.
Daelemans D; Pannecouque C; Pavlakis GN; Tabarrini O; De Clercq E
Mol Pharmacol; 2005 May; 67(5):1574-80. PubMed ID: 15728798
[TBL] [Abstract][Full Text] [Related]
6. Aspects of successful drug discovery and development.
Pauwels R
Antiviral Res; 2006 Sep; 71(2-3):77-89. PubMed ID: 16828174
[TBL] [Abstract][Full Text] [Related]
7. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
Cao YL; Guo Y
Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
[TBL] [Abstract][Full Text] [Related]
8. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel Vpr-binding compound that inhibits HIV-1 multiplication in macrophages by chemical array.
Hagiwara K; Murakami T; Xue G; Shimizu Y; Takeda E; Hashimoto Y; Honda K; Kondoh Y; Osada H; Tsunetsugu-Yokota Y; Aida Y
Biochem Biophys Res Commun; 2010 Dec; 403(1):40-5. PubMed ID: 21036153
[TBL] [Abstract][Full Text] [Related]
10. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors.
Blair WS; Isaacson J; Li X; Cao J; Peng Q; Kong GF; Patick AK
Antiviral Res; 2005 Feb; 65(2):107-16. PubMed ID: 15708637
[TBL] [Abstract][Full Text] [Related]
11. New targets for inhibitors of HIV-1 replication.
Moore JP; Stevenson M
Nat Rev Mol Cell Biol; 2000 Oct; 1(1):40-9. PubMed ID: 11413488
[TBL] [Abstract][Full Text] [Related]
12. Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.
Esimone CO; Grunwald T; Nworu CS; Kuate S; Proksch P; Uberla K
Chemotherapy; 2009; 55(2):119-26. PubMed ID: 19155620
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay.
Michelini Z; Galluzzo CM; Negri DR; Leone P; Amici R; Bona R; Summa V; Di Santo R; Costi R; Pommier Y; Marchand C; Palmisano L; Vella S; Cara A
J Virol Methods; 2010 Sep; 168(1-2):272-6. PubMed ID: 20558207
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.
Ghosn J; Chaix ML; Delaugerre C
AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858
[TBL] [Abstract][Full Text] [Related]
15. A high-throughput drug screening system for HIV-1 transcription inhibitors.
Kempf MC; Jones J; Heil ML; Kutsch O
J Biomol Screen; 2006 Oct; 11(7):807-15. PubMed ID: 16831859
[TBL] [Abstract][Full Text] [Related]
16. Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations.
Li J; Li L; Li HP; Zhuang DM; Liu SY; Liu YJ; Bao ZY; Wang Z; Li JY
Chin Med J (Engl); 2009 May; 122(9):1081-6. PubMed ID: 19493444
[TBL] [Abstract][Full Text] [Related]
17. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E
Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440
[TBL] [Abstract][Full Text] [Related]
18. Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.
Piscitelli F; Coluccia A; Brancale A; La Regina G; Sansone A; Giordano C; Balzarini J; Maga G; Zanoli S; Samuele A; Cirilli R; La Torre F; Lavecchia A; Novellino E; Silvestri R
J Med Chem; 2009 Apr; 52(7):1922-34. PubMed ID: 19281225
[TBL] [Abstract][Full Text] [Related]
19. Screening of small-molecule compounds as inhibitors of HCV entry.
Yang JP; Zhou D; Wong-Staal F
Methods Mol Biol; 2009; 510():295-304. PubMed ID: 19009270
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.
Rice WG; Turpin JA; Schaeffer CA; Graham L; Clanton D; Buckheit RW; Zaharevitz D; Summers MF; Wallqvist A; Covell DG
J Med Chem; 1996 Sep; 39(19):3606-16. PubMed ID: 8809151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
